Good morning . China urges banks to curb their Treasuries exposure, while Goldman tells traders to buckle up for the week ahead. And congratulations to the 12s in Seattle and beyond. Listen to the day’s top stories . S&P 500 Futures 6,935.5 -0.25% Nasdaq Futures 25,047.25 -0.46% Bloomberg Dollar Spot Index 1,187.41 -0.27% Chinese regulators have advised financial institutions to rein in their hold...
Good morning . China urges banks to curb their Treasuries exposure, while Goldman tells traders to buckle up for the week ahead. And congratulations to the 12s in Seattle and beyond. Listen to the day’s top stories . S&P 500 Futures 6,935.5 -0.25% Nasdaq Futures 25,047.25 -0.46% Bloomberg Dollar Spot Index 1,187.41 -0.27% Chinese regulators have advised financial institutions to rein in their holdings of US Treasuries, citing concerns over concentration risks and market volatility, according to people familiar. The move was framed around diversifying risk , but geopolitical tensions remain—the latest source of which may be the sentencing of pro-democracy former media mogul Jimmy Lai to 20 years in prison . Iranian President Masoud Pezeshkian described nuclear talks with the US as “ a step forward ,” while Donald Trump said that another meeting was set for this week. Israeli Prime Minister Benjamin Netanyahu will head to Washington to meet Trump on Wednesday to push him to impose limits on Tehran’s missiles and proxies. In the UK, Prime Minister Keir Starmer is facing huge pressure on his leadership. A crisis over the appointment of Peter Mandelson as ambassador to the US, despite ties to Jeffrey Epstein, is intensifying and now Starmer’s top aide has quit, along with his head of communications . How the Debt Problem is Fueling the Gold Market Watch the Video Turning to corporate news: Apple is set to kick off a product blitz this year with the iPhone 17e, updated iPads and fresh Macs . And Apollo Global Management is teaming up with Schroders to develop funds for wealth and pension clients . And looking ahead, Goldman’s traders say “buckle up” for choppy stocks trading this week as algorithmic funds sell. Don’t forget the January jobs report comes out Wednesday, having been delayed by the partial government shutdown. And inflation data is due Friday, putting two of the most consequential data snapshots unusually close together. Deep Dive: Private School Gets Pricy T...
(RTTNews) - Becton, Dickinson and Company (BDX) will host a conference call at 8:00 AM ET on February 9, 2026, to discuss Q1 26 earnings results. To access the live webcast, log on to https://investors.bd.com/news-events/ir-calendar/detail/20260209-q1-fy26-bd-earnings-conference-call The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect tho...
(RTTNews) - Becton, Dickinson and Company (BDX) will host a conference call at 8:00 AM ET on February 9, 2026, to discuss Q1 26 earnings results. To access the live webcast, log on to https://investors.bd.com/news-events/ir-calendar/detail/20260209-q1-fy26-bd-earnings-conference-call The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In this article NVO HIMS Follow your favorite stocks CREATE FREE ACCOUNT The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. Tom Little | Reuters Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker's new Wegovy obesity pill ...
In this article NVO HIMS Follow your favorite stocks CREATE FREE ACCOUNT The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. Tom Little | Reuters Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker's new Wegovy obesity pill and injections in the U.S. Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe on the company's patents, and is seeking to recover damages. In a release, Novo accused Hims of "deceiving patients and putting their health at risk," as the safety, efficacy and quality of those copies are not verified by U.S. regulators. The move escalates the feud between Novo and Hims, which said on Saturday it will stop offering its new obesity pill copycat after facing scrutiny from federal regulators and legal threats from the Danish drugmaker. Hims had planned to offer the oral drug for as little as $49 for the first month, roughly $100 less than Novo's approved Wegovy pill. The lawsuit comes as Novo works to reclaim market share in the booming obesity drug market and fend off competition from both Eli Lilly and a wave of compounded alternatives. Those copycats have proliferated under a regulatory loophole that allows companies like Hims to sell compounded versions of patent-protected drugs when branded treatments are in short supply. Semaglutide — the active ingredient in Novo's pill and its blockbuster injections — is no longer in shortage in the U.S., thanks to the company's efforts to ramp up manufacturing capacity. There are no shortages reported for the Wegovy pill, which has had an explosive launch since it entered the U.S. market in early January. Even so, Novo estimated in January that as many as 1.5 million Americans are using compounded GLP-1 drugs. Hims has said its compounded pill and other GLP-1 products contain semagl...
Monty Rakusen/DigitalVision via Getty Images Listen below or on the go via Apple Podcasts and Spotify Biggest stock movers Monday: SOFI, HIMS, and more. (00:15) Samsung ( SSNLF ) shares jump on report of imminent HBM4 mass production. (01:03) China's Luckin Coffee ( LKNCY ) targets Starbucks ’ ( SBUX ) premium market with first flagship store. (01:38) This is an abridged transcript. Hims & Hers He...
Monty Rakusen/DigitalVision via Getty Images Listen below or on the go via Apple Podcasts and Spotify Biggest stock movers Monday: SOFI, HIMS, and more. (00:15) Samsung ( SSNLF ) shares jump on report of imminent HBM4 mass production. (01:03) China's Luckin Coffee ( LKNCY ) targets Starbucks ’ ( SBUX ) premium market with first flagship store. (01:38) This is an abridged transcript. Hims & Hers Health ( HIMS ) is on our biggest movers list ahead of market opening. HIMS -15% in premarket action. We told you Sunday on Wall Street Brunch that HIMS said it will stop offering a compounded, copycat version of Novo Nordisk’s Wegovy (semaglutide) pill, following pressure from Novo and heightened FDA scrutiny. In a post on X, the company said it decided to discontinue the treatment after “constructive conversations” with industry stakeholders. The move comes after the commissioner of the FDA said regulators would target companies producing mass-market copycat drugs which raises broader concerns around compounded GLP-1 offerings. Novo Nordisk is up 7% percent in premarket action following the announcement. Samsung Electronics' ( SSNLF ) shares rose as much as 6.4% on Monday after a report that the company will soon begin mass production of HBM4 memory chips. The chips are used as part of the buildout for artificial intelligence infrastructure. A news outlet reported that Samsung plans to ship the semiconductors to Nvidia ( NVDA ) as early as the third week of February. The report said, citing unnamed industry sources that the HBM chips will be used to power Nvidia's upcoming Vera Rubin AI accelerators. Luckin Coffee ( LKNCY ) continues to take aim at Starbucks ( SBUX ). The coffee chain announced the official inauguration of its 30,000th store on Sunday. It's the first Origin Flagship, in Shenzhen. China’s Luckin Coffee is targeting Starbucks’ high-end roastery market with the new flagship in the south, marking its first major shift from budget stores that once helped it surp...
This is part of a series on the new realities of finance. While banks tout efficiency gains they’ve both achieved and project from AI, fears persist that the technology could hollow out entry-level roles . What is clear is that employers are onboarding classes of financial analysts for whom using AI models is second nature. It’s possible their fluency, and their openness to experimenting with evol...
This is part of a series on the new realities of finance. While banks tout efficiency gains they’ve both achieved and project from AI, fears persist that the technology could hollow out entry-level roles . What is clear is that employers are onboarding classes of financial analysts for whom using AI models is second nature. It’s possible their fluency, and their openness to experimenting with evolving tools, may be giving younger workers a leg up on their elders. We talked to junior bankers about what their early career looks like as AI creeps in. The Engineer Hailey Mullen, 24 Hailey Mullen has always used technology to make sense of the world. At Dartmouth College, she studied engineering and got a master’s degree in operations research and analytics, working with professors who embraced AI as a tool of the future, with models performing quantum-physics calculations and multivariable calculus. “I got to approach AI with a lot of curiosity and creativity in a very unstructured, unregulated environment,” she says. After completing two summer internships with Morgan Stanley , Mullen started as a full-time analyst at the bank this past July, and her background has come in handy. Members of her team, which works on deals related to media and digital infrastructure, regularly ask her for assistance with AI-related tasks such as structuring effective prompts. “We have hundreds upon hundreds of deal folders, with decades of models and analysis and PowerPoints, and truly everything you do in banking could be aided by finding precedent analysis,” Mullen says of the comparison between a company’s metrics and those of peers in prior deals. “If you have a good precedent, your life becomes much easier.” For a recent deal with a data-center operator, she had little background information to work with and two related financial models that were “extremely complex and dense.” One spreadsheet had 40-plus tabs and thousands of rows of data, but AI helped her analyze, synthesize and c...
Erling Haaland says Manchester City’s dramatic 2-1 win at Liverpool on Sunday meant more than just the points and represented a statement from the club in terms of the Premier League title race. City had won only once at Anfield under Pep Guardiola – during the 2020-21 fan-free Covid season – and went there on a run of one victory in six in the league which had allowed Arsenal to pull clear at the...
Erling Haaland says Manchester City’s dramatic 2-1 win at Liverpool on Sunday meant more than just the points and represented a statement from the club in terms of the Premier League title race. City had won only once at Anfield under Pep Guardiola – during the 2020-21 fan-free Covid season – and went there on a run of one victory in six in the league which had allowed Arsenal to pull clear at the top. City were nine points behind in second place at kick-off and their hopes looked set to evaporate as they trailed to Dominic Szoboszlai’s sensational 74th-minute free-kick. But Bernardo Silva got City back into it with six minutes of normal time to play before Haaland scored what proved to be the winner from the penalty spot in the third minute of stoppage time. The City goalkeeper, Gianluigi Donnarumma, would deny Alexis Mac Allister with a fabulous save in the 99th minute. And there was still time for the City substitute Rayan Cherki to have a goal disallowed from the halfway line and Szoboszlai to be sent off. When it was over, with the City fans ecstatic, it was difficult not to see it as a mood-changer, a potential turning point. Haaland was asked whether the win was bigger than just the three points. “It’s three points, it’s three points, it’s three points, simple as that, no matter who you play … if it is Tottenham or whatever,” Haaland said. “But I know what you mean. And yes, definitely, it’s true.” Was it a statement result? “Of course,” Haaland replied. “And look at the emotions with the fans in the end. It was amazing. They deserve it after supporting us week in, week out. Yeah, they definitely deserve to win at Anfield.” Haaland was also asked whether City had sent a message to Arsenal, who are next in action at Brentford on Thursday night. City play 24 hours earlier at home to Fulham. “No, not really,” Haaland said. “But it sends a good statement to our fans. “We’ve seen before that the title race is not over until it’s over. I need to recover, eat some g...
The world’s largest pencil maker has accused the Costa Rican government of misusing an old factory that the German manufacturer donated for humanitarian purposes – by detaining asylum seekers there who were deported from the US by the Trump administration last year. Faber-Castell produces more than 2bn wooden pencils a year worldwide and used to have a factory in the southern part of Costa Rica, b...
The world’s largest pencil maker has accused the Costa Rican government of misusing an old factory that the German manufacturer donated for humanitarian purposes – by detaining asylum seekers there who were deported from the US by the Trump administration last year. Faber-Castell produces more than 2bn wooden pencils a year worldwide and used to have a factory in the southern part of Costa Rica, bordering Panama and supplied by trees cultivated in the region. But it closed it down in 2013 because of adverse economic factors, and in 2018 the facility was gifted to Costa Rica by Faber-Castell. In a contract between the company and the ministry of public security, shared with the Guardian, Faber-Castell specified that the premises would be used as a shelter to offer refuge and humanitarian assistance for people migrating through the region. However, last year it appears conditions at the facility changed and people were locked up, with Faber-Castell unaware of this until contacted by the Guardian last month. The German pencil maker’s donation of the buildings in 2018 was in response to an increase in Nicaraguans fleeing across the border to Costa Rica amid a violent crackdown on protesters by Nicaragua’s government. The company said in the contract that the property was to be used to “house a shelter for the care of migrants … without the possibility of changing the purpose of the property”. There are no reports that Nicaraguans or others accommodated at the disused factory were kept in detention – until Costa Rica accepted 200 deportees from the US and locked them up at the former factory, since named Centro de Atención Temporal para Migrantes, or Catem. When the Guardian approached Faber-Castell for comment, the company said it had not realized anyone had been detained at Catem. “We agreed and stipulated in the contract that the building was to be transformed into a humanitarian refugee center, and under no circumstances was it agreed to be used as a prison,” represe...
DKosig/iStock via Getty Images For nearly two years, markets were driven by the same speculative narrative that “ this time is different.” Bitcoin, precious metals, and AI-linked equities rose not only because of robust fundamentals but also because investors clung to powerful narratives about inflation, disruption, and monetary collapse. Those speculative narratives are not only seductive but als...
DKosig/iStock via Getty Images For nearly two years, markets were driven by the same speculative narrative that “ this time is different.” Bitcoin, precious metals, and AI-linked equities rose not only because of robust fundamentals but also because investors clung to powerful narratives about inflation, disruption, and monetary collapse. Those speculative narratives are not only seductive but also contribute to investment behaviors that obscure reality. Bitcoin was cast as “digital gold,” a hedge against a largely false tale of a weakening dollar and fiscal instability . Gold and silver were likewise falsely elevated as defensive stores of value in a monetary regime supposedly at risk of losing purchasing power . AI stocks became shorthand for a new productivity supercycle where profits would follow indefinitely rising valuations . These speculative narratives are fine and drive bull markets in the near term. As John Maynard Keynes once quipped: “Markets can remain irrational longer than you can remain solvent ,” and those narratives are potent as they frame expectations and justify positions. However, these speculative narratives have little to do with economic or fundamental realities that will ultimately drive outcomes. In markets, stories don’t replace valuation. As I noted previously, when “valuation metrics are excessive… it is a better measure of investor psychology than fundamentals.” That means price becomes more about sentiment than business results, and we see that in the relationship between consumer sentiment about stock prices over the next 12 months and valuations. “This broad wave of bullish behavior isn’t isolated to sentiment surveys. Positioning data, equity fund inflows, and trading behavior confirm the lack of bears in the market. Markets are rising not because of strong earnings or economic acceleration, but because of optimism about future prices. In this environment, price momentum drives buying, not fundamentals. We see that in the overlay ...
– First quarter fiscal 2026 revenue increased 0.8% compared to prior year quarter to $120.9 million – First quarter fiscal 2026 operating loss increased 5.3% compared to prior year quarter to $16.3 million – Conference call scheduled for today at 8:30 am ET WEST LAFAYETTE, Ind., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization ...
– First quarter fiscal 2026 revenue increased 0.8% compared to prior year quarter to $120.9 million – First quarter fiscal 2026 operating loss increased 5.3% compared to prior year quarter to $16.3 million – Conference call scheduled for today at 8:30 am ET WEST LAFAYETTE, Ind., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (“Q1 FY 2026”) ended December 31, 2025. Revenue by Segment (in millions of USD) Three Months Ended December 31, % change(1) 2025 2024 (unaudited) (unaudited) DSA (Discovery & Safety Assessment) $ 48.0 $ 42.8 12.0 % RMS (Research Models & Services) $ 72.9 $ 77.1 (5.4 )% Total(1) $ 120.9 $ 119.9 0.8 % (1) Table may not foot and percentages may not recalculate due to rounding. Management Commentary Robert Leasure Jr., President and Chief Executive Officer, commented, “During the first quarter of fiscal 2026, we continued to execute on our operational and financial priorities, with a sustained focus on client service and margin discipline. Revenue increased slightly compared to the first quarter of fiscal 2025, and demand trends, particularly within our DSA segment, remained encouraging and reflect the value clients place on our capabilities and partnership approach.” “Client satisfaction and reliable, on-time delivery of high-quality products and services remain central to our strategy. In the first quarter, DSA revenue increased 12.0% compared with the prior-year period, and DSA net awards grew approximately 27% year-over-year. These results underscore the progress we are making toward building durable client relationships and a growing base of recurring business. We continue to advance our strategic initiatives and appreciate the continued support and trust of our employees, shareholde...
HOBOKEN, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, today reported financial results for its fiscal second quarter ended December 31, 2025. “We demonstrated meaningful strategic and operational progress in the second quarter and are ad...
HOBOKEN, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, today reported financial results for its fiscal second quarter ended December 31, 2025. “We demonstrated meaningful strategic and operational progress in the second quarter and are advancing our turnaround strategy with urgency. We took bold steps to sharpen our portfolio and strengthen our balance sheet through the divestiture of our North American snack business, giving us greater financial flexibility alongside an improved margin and cash flow profile. Our core categories are stable, our operational execution is improving, and we demonstrated strong cash delivery in the quarter. The actions underway across simplification, pricing, innovation, and productivity provide a clear path to sequential improvement in the back half of the year. We remain confident in our path forward,” stated Alison Lewis, President and CEO. FINANCIAL HIGHLIGHTS* Summary of Fiscal Second Quarter Results Compared to the Prior Year Period Net sales were $384 million, down 7% year-over-year. Organic net sales decreased 7% compared to the prior year period. The decrease in organic net sales was comprised of a 9-point decrease in volume/mix, partially offset by a 2-point increase in pricing. Gross profit margin was 19.4%, a 330-basis point decrease from the prior year period. Adjusted gross profit margin was 19.5%, a 340-basis point decrease from the prior year period. Net loss was $116 million, compared to a net loss of $104 million in the prior year period. Net loss included pre-tax non-cash impairment charges of $132 million ($131 million after-tax) related to goodwill and certain intangible assets. Adjusted net loss was $3 million, compared to adjusted net income of $8 million in the prior year period. Adjusted EBITDA was $24 million, compared to $38 million in the prior year p...
RA'ANANA, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN,IINNW) (“Inspira Technologies” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced a pivotal commercial advancement. The Company has received official approval from the Medical Equipment Committee of Clalit Health Services (“Clalit”), recognized a...
RA'ANANA, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN,IINNW) (“Inspira Technologies” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced a pivotal commercial advancement. The Company has received official approval from the Medical Equipment Committee of Clalit Health Services (“Clalit”), recognized as the second-largest integrated Health Maintenance Organization (HMO) globally. The approval enables the INSPIRA™ ART100 system for immediate procurement and operational use across Clalit's extensive medical ecosystem. Key Highlights: Commercial Activation: The approval transitions the ART100 from regulatory clearance to active commercial availability within a network serving approximately 4.9 million members. Tier-1 Network Scale: Clalit operates 14 major hospitals (including Rabin Medical Center and Soroka Medical Center, often ranked among Newsweek's "World's Best Smart Hospitals") and over 1,600 clinics. This approval effectively opens the door to one of the most sophisticated healthcare supply chains in the world. Validation of Clinical Value: The approval follows a rigorous technical and clinical review by the Professional Committee for Medical Equipment regarding Thoracic and Cardiac Surgery, signaling strong validation of the ART100’s safety and efficacy profile to other global health systems. "Securing vendor status with a health network of Clalit's magnitude, comparable in scale to leading U.S. integrated systems like Kaiser Permanente, is a definitive commercial inflection point for Inspira," stated Dagi Ben-Noon, CEO of Inspira Technologies. "By securing this approval, we are laying the foundation for potentially long-term, high-quality revenue. This validation from a world-class, data-driven health ecosystem serves as a powerful reference case as we accelerate our commercialization efforts in the U.S. and other global markets." The Company views this approval a...
TORONTO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX-V: EMO; OTCQX: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) reports results from ongoing drilling of El Cura deposit. El Cura is part of Emerita’s wholly owned Iberian Belt West project (“IBW” or the “Project”; Figure 1) which hosts three Volcanogenic Massive Sulfide (VMS) deposits: La Romanera, El Cura and La Infanta that a...
TORONTO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX-V: EMO; OTCQX: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) reports results from ongoing drilling of El Cura deposit. El Cura is part of Emerita’s wholly owned Iberian Belt West project (“IBW” or the “Project”; Figure 1) which hosts three Volcanogenic Massive Sulfide (VMS) deposits: La Romanera, El Cura and La Infanta that are currently undergoing Prefeasibility Studies (the “PFS”) (see the Company’s press release dated December 3, 2025). Recent results from the ongoing drilling at El Cura are listed below and complete data is included in Table 1. Drill hole EC094: 9.2m grading 1.4% copper, 0.4% lead, 1.3% zinc, 0.41 g/t gold and 21.48 g/t silver Drill hole EC089: 2.8m grading 0.6% copper, 0.5% lead, 1.6% zinc, 1.71 g/t gold and 30.95 g/t silver Drill hole EC093: 5.6m grading 1.2% copper, 0.6% lead, 1.3% zinc, 0.82 g/t gold and 28.00 g/t silver Drill hole EC090: 3.0m grading 0.3% copper, 0.7% lead, 2.2% zinc, 0.36 g/t gold and 24.00 g/t silver Figure 1. IBW tenement and locations of La Romanera, El Cura and La Infanta deposits. View Figure 1 here: https://www.globenewswire.com/NewsRoom/AttachmentNg/3533bec4-6ecd-4313-964f-abef2228530c Table 1 shows drill hole location and assay data; drill hole traces are shown in map view in Figure 2. Long-section and cross-section views are displayed in Figures 3 and 4. Photos of mineralized core intercepts are shown in Figure 5. Table 1: Recent drilling results received for El Cura deposit. True width ranged from 84% to 98% of intercept width, except for EC089 (true width 64% of intercept width). DDH Easting Northing Elevation Azimuth Dip Depth (m) FROM TO Width (m) Cu % Pb % Zn % Au g/t Ag g/t EC089 649834 4171569 126 201 -68 465.9 426.95 429.75 2.8 0.6 0.5 1.6 1.71 30.95 EC090 649685 4171500 127 175 -36 251.5 231.1 234.1 3.0 0.3 0.7 2.2 0.36 24.00 EC093 649834 4171569 126 165 -50 298 278.95 284.55 5.6 1.2 0.6 1.3 0.82 28.00 EC094 650050 4171540 135 178 -3...
New design center to focus on cutting-edge AI fabrics and emerging AI inference technologies Industry veteran Guy Azrad to lead operations as general manager of Astera Labs Israel SAN JOSE, Calif. and TEL AVIV, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced a signif...
New design center to focus on cutting-edge AI fabrics and emerging AI inference technologies Industry veteran Guy Azrad to lead operations as general manager of Astera Labs Israel SAN JOSE, Calif. and TEL AVIV, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced a significant expansion of its global engineering operations with the establishment of an advanced research and development center in Israel. The new design center will accelerate the development of Astera Lab’s next-generation scale-up fabrics for high-bandwidth connectivity protocols, while also advancing technical research and development to address memory bottlenecks in AI training and inference applications. Semiconductor industry veteran Guy Azrad, senior vice president of engineering and general manager of Astera Labs Israel, will lead the new Israel operations, and will be supported by Ido Bukspan as vice president of ASIC engineering. Astera Labs is expanding its global engineering footprint with the new Israel design center as a strategic investment in one of the world's premier semiconductor ecosystems. The new center creates an end-to-end facility for advanced research and development of connectivity solutions in Israel that aims to solve critical data, network, and memory bottlenecks. Through collaborations with leading Israeli universities and the venture ecosystem, the design center is expected to serve as a hub to advance technologies critical to support next-generation AI infrastructure worldwide. “We’re building an engineering team with a strong focus on execution, covering hardware, silicon, and software solutions, to support the growing adoption of Astera Labs’ Intelligent Connectivity Platform,” said Guy Azrad, senior vice president of Engineering and general manager of Astera Labs Israel. “With offices in Tel Aviv and Haifa, the new Israel design center will l...
Guy Azrad brings extensive semiconductor leadership experience in high-speed networking, compute, and Ethernet technologies to his role as general manager of the Israel design center. He most recently served as vice president of chip design engineering at Google, where he led silicon development for compute applications. Prior to Google, he held senior engineering leadership roles at Marvell, wher...
Guy Azrad brings extensive semiconductor leadership experience in high-speed networking, compute, and Ethernet technologies to his role as general manager of the Israel design center. He most recently served as vice president of chip design engineering at Google, where he led silicon development for compute applications. Prior to Google, he held senior engineering leadership roles at Marvell, where he was senior vice president of the company's global Ethernet switching division, overseeing development of advanced networking solutions deployed across data centers worldwide. His career spans deep expertise in developing advanced networking system-on-chips (SoCs), building and scaling large-scale chip design organizations across multiple geographies, and delivering complex silicon solutions from architecture through production. Azrad has been instrumental in bringing multiple generations of high-performance networking products to market. “We’re building an engineering team with a strong focus on execution, covering hardware, silicon, and software solutions, to support the growing adoption of Astera Labs’ Intelligent Connectivity Platform,” said Guy Azrad, senior vice president of Engineering and general manager of Astera Labs Israel. “With offices in Tel Aviv and Haifa, the new Israel design center will look to tap into the region's world-class engineering talent to focus on the full chip design flow—from architecture through production, including software and system design for cutting-edge AI fabrics and emerging inference applications.” Astera Labs is expanding its global engineering footprint with the new Israel design center as a strategic investment in one of the world's premier semiconductor ecosystems. The new center creates an end-to-end facility for advanced research and development of connectivity solutions in Israel that aims to solve critical data, network, and memory bottlenecks. Through collaborations with leading Israeli universities and the venture ecos...
A denser-than-usual jobs report is expected to show just how much the US labor market has slowed in recent years — or perhaps that it wasn’t growing at all. In addition to the usual monthly payrolls and unemployment data, the January jobs report, due Wednesday , also includes highly anticipated revisions to payrolls. Those are expected to substantially mark down the pace of hiring, after a prelimi...
A denser-than-usual jobs report is expected to show just how much the US labor market has slowed in recent years — or perhaps that it wasn’t growing at all. In addition to the usual monthly payrolls and unemployment data, the January jobs report, due Wednesday , also includes highly anticipated revisions to payrolls. Those are expected to substantially mark down the pace of hiring, after a preliminary estimate suggested a record downward adjustment of 911,000 in the year through March 2025. “The annual benchmark revisions are going to be more consequential than normal this year,” said Scott Anderson , chief US economist at BMO Capital Markets. “Right now the labor market does appear to be on a knife’s edge between net job growth and maybe job loss.” The report, which is produced by the Bureau of Labor Statistics , was originally scheduled for Feb. 6 but was delayed by the partial government shutdown . With the release of each January employment report, BLS benchmarks payrolls to a more accurate but less timely series called the Quarterly Census of Employment and Wages. That data is based on state unemployment insurance tax records and covers most US jobs. In addition to the newly adjusted employment level for March 2025, BLS will release revised monthly payroll changes throughout last year. Those revisions also reflect the agency’s update to its model that accounts for business openings and closures as well as new seasonal adjustment factors. The labor market was already understood to be gradually weakening last year, through what economists largely dubbed a “low-hire, low-fire” environment. But the revisions may indicate an even sharper slowdown in hiring than previously thought. That could change how the Federal Reserve views the labor market, which Chair Jerome Powell recently described as one that is showing signs of stabilization . He’s said that job growth has probably been overstated, but that the economy is in a solid enough position for officials to hold in...
The chemical giant Corteva will stop producing Enlist Duo, a herbicide considered to be among the most dangerous still used in the US by environmentalists because it contains a mix of Agent Orange and glyphosate, which have both been linked to cancer and widespread ecological damage. The US military deployed Agent Orange, a chemical weapon, to destroy vegetation during the Vietnam war, causing ser...
The chemical giant Corteva will stop producing Enlist Duo, a herbicide considered to be among the most dangerous still used in the US by environmentalists because it contains a mix of Agent Orange and glyphosate, which have both been linked to cancer and widespread ecological damage. The US military deployed Agent Orange, a chemical weapon, to destroy vegetation during the Vietnam war, causing serious health problems among soldiers and Vietnamese residents. Glyphosate, meanwhile, is a highly controversial and toxic herbicide ingredient that has prompted similar litigation. Both are banned or severely restricted in many industrialized countries. Despite the risks of combining the substances, the US Environmental Protection Agency has twice approved it for use on food crops. The compound is annually spread on around 4.5m acres of fields in which corn, soybeans and genetically engineered cotton are grown. The move will bring to an end a decade of litigation and public pressure campaigns to ban Enlist Duo, and advocates are “celebrating it as a win”, said Kristina Sinclair, a staff attorney with the Center for Food Safety (CFS) non-profit, which is a lead plaintiff in the lawsuit. “After over a decade of legal battles, rather than try to rebut our arguments in court, the manufacturer pulled Enlist Duo from the market,” Sinclair said. “Our food system never should have been doused in this toxic cocktail, and now never will be again.” Corteva did not immediately respond to a request for comment, and Sinclair said it was unclear why the company decided to pull Enlist Duo. Corteva reported selling more than $1bn in Enlist products in 2022. The Agent Orange chemical 2,4-D will still be used in Enlist One, and a lawsuit that asks a judge to invalidate its approval will continue. 2,4-D works by attacking the roots and leaves of weeds and causing them to produce unwanted cells, not unlike inducing cancer, to kill or hobble them. The substance is considered a “possible” carcinog...
As rumors swirl about a SpaceX IPO, Elon Musk's rocket ship company makes an even bigger move. One of the biggest financial storylines so far in 2026 revolves around whether or not SpaceX will go public. While some headlines suggest Elon Musk's space exploration company has been meeting with investment banks to talk about an initial public offering (IPO), a new chapter is swiftly being written as ...
As rumors swirl about a SpaceX IPO, Elon Musk's rocket ship company makes an even bigger move. One of the biggest financial storylines so far in 2026 revolves around whether or not SpaceX will go public. While some headlines suggest Elon Musk's space exploration company has been meeting with investment banks to talk about an initial public offering (IPO), a new chapter is swiftly being written as that narrative unfolds. On Feb. 2, Musk announced a merger of SpaceX and his artificial intelligence (AI) start-up, xAI, and valued the company at $1.25 trillion. The combination of these two assets makes a potential SpaceX IPO all the more interesting. Nevertheless, I find these talking points to be totally distracting. Below, I'll explain why merging xAI and SpaceX makes strategic sense. But more importantly, I'll reveal my top stock pick at the intersection of AI and space exploration. Spoiler alert: It has nothing to do with Musk. Does the SpaceX merger with xAI make sense? On the surface, merging an AI start-up with a rocket ship company looks silly. When it comes to Musk, however, there are always several layers to the equation. Throughout his tenure as CEO of Tesla, Musk has often hinted at a desire to merge SpaceX with the electric vehicle (EV) company. Notably, Tesla recently received shareholder approval to make a $2 billion investment in xAI. Merging xAI with SpaceX, as well as Tesla's decision to make a strategic investment in xAI, comes down to one thing: Musk's obsession with control. From a governance perspective, combining xAI with SpaceX provides Musk with far more oversight of his two prized possessions. From a technological standpoint, xAI and SpaceX can certainly complement one another. Space systems generate large volumes of critical information. Take Starlink as an example: Its network collects data across various geographies, weather patterns, and user habits, and creates satellite and orbital imagery. Thanks to AI, space infrastructure can use this i...
Guy Azrad brings extensive semiconductor leadership experience in high-speed networking, compute, and Ethernet technologies to his role as general manager of the Israel design center. He most recently served as vice president of chip design engineering at Google, where he led silicon development for compute applications. Prior to Google, he held senior engineering leadership roles at Marvell, wher...
Guy Azrad brings extensive semiconductor leadership experience in high-speed networking, compute, and Ethernet technologies to his role as general manager of the Israel design center. He most recently served as vice president of chip design engineering at Google, where he led silicon development for compute applications. Prior to Google, he held senior engineering leadership roles at Marvell, where he was senior vice president of the company's global Ethernet switching division, overseeing development of advanced networking solutions deployed across data centers worldwide. His career spans deep expertise in developing advanced networking system-on-chips (SoCs), building and scaling large-scale chip design organizations across multiple geographies, and delivering complex silicon solutions from architecture through production. Azrad has been instrumental in bringing multiple generations of high-performance networking products to market. “We’re building an engineering team with a strong focus on execution, covering hardware, silicon, and software solutions, to support the growing adoption of Astera Labs’ Intelligent Connectivity Platform,” said Guy Azrad, senior vice president of Engineering and general manager of Astera Labs Israel. “With offices in Tel Aviv and Haifa, the new Israel design center will look to tap into the region's world-class engineering talent to focus on the full chip design flow—from architecture through production, including software and system design for cutting-edge AI fabrics and emerging inference applications.” Astera Labs is expanding its global engineering footprint with the new Israel design center as a strategic investment in one of the world's premier semiconductor ecosystems. The new center creates an end-to-end facility for advanced research and development of connectivity solutions in Israel that aims to solve critical data, network, and memory bottlenecks. Through collaborations with leading Israeli universities and the venture ecos...
2026-02-09 | ORCL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Oracle Corporation Investors with Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:ORCL | Press Release Stockhouse
2026-02-09 | ORCL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Oracle Corporation Investors with Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:ORCL | Press Release Stockhouse